Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Cause-Specific Cardiovascular Death in Patients with CKD: A Meta-Analysis of CKD Progression Trials.

Robert A Fletcher,William G Herrington, Rajiv Agarwal,Kaitlin J Mayne,Clare Arnott, Meg J Jardine,Kenneth W Mahaffey, Vlado Perkovic,Natalie Staplin,David C Wheeler,Glenn M Chertow, Hiddo J L Heerspink,Brendon L Neuen

Clinical journal of the American Society of Nephrology : CJASN（2024）

Cited 0|Views10

No score

Abstract

Clinical Trial registry name and registration number: ClinicalTrials.gov Identifiers: NCT02065791 (CREDENCE), NCT03036150 (DAPA-CKD), NCT03594110 (EMPA-KIDNEY).

Translated text

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined